BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
0.55%
4.00p
735.00p
17:17 23/11/17
735.00p
17:17 23/11/17
DAILY VARIATION
0.55%
4.00p
VOLUME
243,956
REAL TIME BATS
735.00p
17:36 23/11/17
0.48%
3.50p
DATA
52 Week High
779.00p
52 Week Low
534.50p
Shares Issued
386.40m
Market Cap
£2,840.03m
RiskGrade
n/a
Beta
0.72
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 10.1% 23.3%
ROCE 24.7%
Latest F'cast
P/E 31.9 24.2
PEG 5.8 0.9
Pr/Revenue 5.0 4.6
Pr/Book 2.9
Latest F'cast
Revenue 27.5% -7.6%
PBT -45.0% n/a
EPS 5.5% -10.0%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%
2016-03-31 447.50 57.50 21.90p 28.4 0.7 39% n/a 0.0%
2017-03-31 570.50 31.60 23.10p 25.4 4.6 5% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2018-03-31 601.89 140.00 29.45p 24.2 0.9 27% 0.00p 0.0%
2019-03-31 632.06 162.52 33.26p 21.8 1.7 13% 0.00p 0.0%

Regulatory News

slide to see more
Holding(s) in Company 16-Nov-17 16:37
Directorate Change 14-Nov-17 07:07
Half-year Report 14-Nov-17 07:04

Newspaper Links

No results found